Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
BACKGROUND: Sjögren’s syndrome (SjS), one of the most common autoimmune diseases, impacts millions of people annually. SjS results from autoimmune attack on exocrine (salivary and lacrimal) glands, and women are nine times more likely to be affected than men. To date, no vaccine or therapeutic exist...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022426/ https://www.ncbi.nlm.nih.gov/pubmed/33823920 http://dx.doi.org/10.1186/s13075-021-02475-1 |
_version_ | 1783674924882198528 |
---|---|
author | Akgul, Ali Maddaloni, Massimo Jun, Sang Mu Nelson, Andrew S. Odreman, Vanessa Aguilera Hoffman, Carol Bhagyaraj, Ella Voigt, Alexandria Abbott, Jeffrey R. Nguyen, Cuong Q. Pascual, David W. |
author_facet | Akgul, Ali Maddaloni, Massimo Jun, Sang Mu Nelson, Andrew S. Odreman, Vanessa Aguilera Hoffman, Carol Bhagyaraj, Ella Voigt, Alexandria Abbott, Jeffrey R. Nguyen, Cuong Q. Pascual, David W. |
author_sort | Akgul, Ali |
collection | PubMed |
description | BACKGROUND: Sjögren’s syndrome (SjS), one of the most common autoimmune diseases, impacts millions of people annually. SjS results from autoimmune attack on exocrine (salivary and lacrimal) glands, and women are nine times more likely to be affected than men. To date, no vaccine or therapeutic exists to treat SjS, and patients must rely on lifelong therapies to alleviate symptoms. METHODS: Oral treatment with the adhesin from enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) fimbriae protects against several autoimmune diseases in an antigen (Ag)-independent manner. Lactococcus lactis, which was recently adapted to express CFA/I fimbriae (LL-CFA/I), effectively suppresses inflammation by the induction of infectious tolerance via Ag-specific regulatory T cells (Tregs), that produce IL-10 and TGF-β. To test the hypothesis that CFA/I fimbriae can offset the development of inflammatory T cells via Treg induction, oral treatments with LL-CFA/I were performed on the spontaneous, genetically defined model for SjS, C57BL/6.NOD-Aec1Aec2 mice to maintain salivary flow. RESULTS: Six-week (wk)-old C57BL/6.NOD-Aec1Aec2 mice were orally dosed with LL-CFA/I and treated every 3 wks; control groups were given L. lactis vector or PBS. LL-CFA/I-treated mice retained salivary flow up to 28 wks of age and showed significantly reduced incidence of inflammatory infiltration into the submandibular and lacrimal glands relative to PBS-treated mice. A significant increase in Foxp3(+) and IL-10- and TGF-β-producing Tregs was observed. Moreover, LL-CFA/I significantly reduced the expression of proinflammatory cytokines, IL-6, IL-17, GM-CSF, and IFN-γ. Adoptive transfer of CD4(+) T cells from LL-CFA/I-treated, not LL vector-treated mice, restored salivary flow in diseased SjS mice. CONCLUSION: These data demonstrate that oral LL-CFA/I reduce or halts SjS progression, and these studies will provide the basis for future testing in SjS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02475-1. |
format | Online Article Text |
id | pubmed-8022426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80224262021-04-07 Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome Akgul, Ali Maddaloni, Massimo Jun, Sang Mu Nelson, Andrew S. Odreman, Vanessa Aguilera Hoffman, Carol Bhagyaraj, Ella Voigt, Alexandria Abbott, Jeffrey R. Nguyen, Cuong Q. Pascual, David W. Arthritis Res Ther Research Article BACKGROUND: Sjögren’s syndrome (SjS), one of the most common autoimmune diseases, impacts millions of people annually. SjS results from autoimmune attack on exocrine (salivary and lacrimal) glands, and women are nine times more likely to be affected than men. To date, no vaccine or therapeutic exists to treat SjS, and patients must rely on lifelong therapies to alleviate symptoms. METHODS: Oral treatment with the adhesin from enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) fimbriae protects against several autoimmune diseases in an antigen (Ag)-independent manner. Lactococcus lactis, which was recently adapted to express CFA/I fimbriae (LL-CFA/I), effectively suppresses inflammation by the induction of infectious tolerance via Ag-specific regulatory T cells (Tregs), that produce IL-10 and TGF-β. To test the hypothesis that CFA/I fimbriae can offset the development of inflammatory T cells via Treg induction, oral treatments with LL-CFA/I were performed on the spontaneous, genetically defined model for SjS, C57BL/6.NOD-Aec1Aec2 mice to maintain salivary flow. RESULTS: Six-week (wk)-old C57BL/6.NOD-Aec1Aec2 mice were orally dosed with LL-CFA/I and treated every 3 wks; control groups were given L. lactis vector or PBS. LL-CFA/I-treated mice retained salivary flow up to 28 wks of age and showed significantly reduced incidence of inflammatory infiltration into the submandibular and lacrimal glands relative to PBS-treated mice. A significant increase in Foxp3(+) and IL-10- and TGF-β-producing Tregs was observed. Moreover, LL-CFA/I significantly reduced the expression of proinflammatory cytokines, IL-6, IL-17, GM-CSF, and IFN-γ. Adoptive transfer of CD4(+) T cells from LL-CFA/I-treated, not LL vector-treated mice, restored salivary flow in diseased SjS mice. CONCLUSION: These data demonstrate that oral LL-CFA/I reduce or halts SjS progression, and these studies will provide the basis for future testing in SjS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02475-1. BioMed Central 2021-04-06 2021 /pmc/articles/PMC8022426/ /pubmed/33823920 http://dx.doi.org/10.1186/s13075-021-02475-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Akgul, Ali Maddaloni, Massimo Jun, Sang Mu Nelson, Andrew S. Odreman, Vanessa Aguilera Hoffman, Carol Bhagyaraj, Ella Voigt, Alexandria Abbott, Jeffrey R. Nguyen, Cuong Q. Pascual, David W. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome |
title | Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome |
title_full | Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome |
title_fullStr | Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome |
title_full_unstemmed | Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome |
title_short | Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome |
title_sort | stimulation of regulatory t cells with lactococcus lactis expressing enterotoxigenic e. coli colonization factor antigen 1 retains salivary flow in a genetic model of sjögren’s syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022426/ https://www.ncbi.nlm.nih.gov/pubmed/33823920 http://dx.doi.org/10.1186/s13075-021-02475-1 |
work_keys_str_mv | AT akgulali stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT maddalonimassimo stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT junsangmu stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT nelsonandrews stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT odremanvanessaaguilera stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT hoffmancarol stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT bhagyarajella stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT voigtalexandria stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT abbottjeffreyr stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT nguyencuongq stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome AT pascualdavidw stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome |